Canagliflozin and metformin hydrochloride

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

diabetes mellitus, type 2

Manufacturer:

Janssen Inc.

Call for patient/clinician input open:

February 3, 2016

Brand Name:

Invokamet

Project Line:

Reimbursement Review

Project Number:

SR0480-000

Call for patient/clinician input closed:

March 24, 2016

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Diabetes mellitus, type 2

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

August 25, 2016

Last Updated : October 10, 2018